ALC

#398
Alcon Inc. Ordinary Shares
66.2 8 USD
+0.49%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
66.19
66.70
Range Annuel
61.84
92.55
Changement quotidien
+0.49%
Changement Mensuel
-9.71%
Evolution sur 6 mois
-16.39%
Changement Annuel
-24.08%
Clôture Précédente
65.9 6
Open
66.4 2
Low
66.1 9
High
66.7 0
Volume
2 248
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 32.31 B
  • Employee 26 K
  • Founded N/A
  • CEO David J. Endicott
  • Website www.alcon.com
  • Headquarter Switzerland
  • FIGI UNKNOWN
  • Industry Instruments et Fournitures Médicales
Chiffre d'affaires total
Résultat net
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie

Alcon Inc. Ordinary Shares

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

Nouvelles